In summary, a novel CS-based nano-complex modified with carboxyl and functionalized with DNA-Apt (as targeting and therapeutic agent) was designed and synthesized for the effective delivery of NO into EGFR-positive breast cancer cells. The gene discussed is EGFR; the disease is breast carcinoma.